UPDATE - Canadian Urological Association Guideline: Male Lower Urinary Tract Symptoms/benign Prostatic Hyperplasia

Overview

Journal Can Urol Assoc J

Specialty Urology

Date 2022 Jul 29

PMID 35905485

Authors

Dean Elterman

Melanie Aube-Peterkin

Howard Evans

Hazem Elmansy

Malek Meskawi

Kevin C Zorn

Naeem Bhojani

Affiliations

Soon will be listed here.

Citing Articles

Urinary Retention After GreenLight Laser Photoselective Vaporization of the Prostate (GLL.PVP) Surgery for Benign Prostatic Hyperplasia (BPH): A 3-6 Month Retrospective Follow-Up Study.

Islam A, Ellis D, Chari N, McComb K, Poushi M, Donkov I Cureus. 2024; 16(11):e73585.

PMID: 39540197 PMC: 11558770. DOI: 10.7759/cureus.73585.

First-Time Successful Trial Without Catheter (TWOC) After GreenLight Laser Photoselective Vaporization of the Prostate (GLL PVP) Surgery for an Enlarged Prostate.

Islam A, Poushi M Cureus. 2024; 16(11):e72982.

PMID: 39502748 PMC: 11536485. DOI: 10.7759/cureus.72982.

Efficacy of Rezūm water vapor therapy for the treatment of catheter-dependent urinary retention A single-center, Canadian experience.

Ramjiawan R, Chung D, Fidel M, Dhillon H, Bal D, Pandian A Can Urol Assoc J. 2024; 19(1):E18-E24.

PMID: 39470665 PMC: 11790040. DOI: 10.5489/cuaj.8808.

Risks and side effects in the medical management of benign prostatic hyperplasia.

Halawani A, Paterson R, Zhong T, Du K, Ren R, Forbes C Prostate Int. 2024; 12(2):57-64.

PMID: 39036761 PMC: 11255900. DOI: 10.1016/j.prnil.2023.11.004.

Long-term outcomes after treatment with Optilume BPH Four-year results from the EVEREST study.

Kaplan S, Pichardo M, Rijo E, Espino G, Rodriguez Lay R, Estrella R Can Urol Assoc J. 2024; 18(11):E319-E325.

PMID: 38976898 PMC: 11534392. DOI: 10.5489/cuaj.8737.

References

Lucas M, Stephenson T, Nargund V . Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia. BJU Int. 2005; 95(3):354-7. DOI: 10.1111/j.1464-410X.2005.05299.x. View

Bhatia S, Sinha V, Harward S, Gomez C, Kava B, Parekh D . Prostate Artery Embolization in Patients with Prostate Volumes of 80 mL or More: A Single-Institution Retrospective Experience of 93 Patients. J Vasc Interv Radiol. 2018; 29(10):1392-1398. DOI: 10.1016/j.jvir.2018.05.012. View

Chapple C . Alpha adrenoceptor antagonists in the year 2000: is there anything new?. Curr Opin Urol. 2001; 11(1):9-16. DOI: 10.1097/00042307-200101000-00002. View

Kaplan S, Roehrborn C, Rovner E, Carlsson M, Bavendam T, Guan Z . Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA. 2006; 296(19):2319-28. DOI: 10.1001/jama.296.19.2319. View

Gravas S, Laguna P, Kiemeney L, de la Rosette J . Durability of 30-minute high-energy transurethral microwave therapy for treatment of benign prostatic hyperplasia: a study of 213 patients with and without urinary retention. Urology. 2007; 69(5):854-8. DOI: 10.1016/j.urology.2007.01.070. View

Roehrborn C, Barkin J, Gange S, Shore N, Giddens J, Bolton D . Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017; 24(3):8802-8813. View

Varkarakis I, Kyriakakis Z, Delis A, Protogerou V, Deliveliotis C . Long-term results of open transvesical prostatectomy from a contemporary series of patients. Urology. 2004; 64(2):306-10. DOI: 10.1016/j.urology.2004.03.033. View

Wilt T, Ishani A, Mac Donald R, Rutks I, Stark G . Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2002; (1):CD001044. PMC: 7032619. DOI: 10.1002/14651858.CD001044. View

Levitt J, Slawin K . Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression. Curr Urol Rep. 2008; 8(4):269-74. DOI: 10.1007/s11934-007-0072-y. View

10.

Patil S, Ranka K, Kundargi V, Guru N . Comparison of tamsulosin and silodosin in the management of acute urinary retention secondary to benign prostatic hyperplasia in patients planned for trial without catheter. A prospective randomized study. Cent European J Urol. 2017; 70(3):259-263. PMC: 5656367. DOI: 10.5173/ceju.2017.1313. View

11.

Ahyai S, Gilling P, Kaplan S, Kuntz R, Madersbacher S, Montorsi F . Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010; 58(3):384-97. DOI: 10.1016/j.eururo.2010.06.005. View

12.

Scarcella S, Castellani D, Gauhar V, Teoh J, Giulioni C, Piazza P . Robotic-assisted versus open simple prostatectomy: Results from a systematic review and meta-analysis of comparative studies. Investig Clin Urol. 2021; 62(6):631-640. PMC: 8566792. DOI: 10.4111/icu.20210297. View

13.

Grubb R, Andriole G, Somerville M, Mahoney C, Manyak M, Castro R . The REDUCE Follow-Up Study: low rate of new prostate cancer diagnoses observed during a 2-year, observational, followup study of men who participated in the REDUCE trial. J Urol. 2012; 189(3):871-7. DOI: 10.1016/j.juro.2012.09.099. View

14.

de la Rosette J, Laguna M, Gravas S, de Wildt M . Transurethral microwave thermotherapy: the gold standard for minimally invasive therapies for patients with benign prostatic hyperplasia?. J Endourol. 2003; 17(4):245-51. DOI: 10.1089/089277903765444393. View

15.

Nestler S, Bach T, Herrmann T, Jutzi S, Roos F, Hampel C . Surgical treatment of large volume prostates: a matched pair analysis comparing the open, endoscopic (ThuVEP) and robotic approach. World J Urol. 2018; 37(9):1927-1931. DOI: 10.1007/s00345-018-2585-z. View

16.

Kably I, Acharya V, Richardson A, Bhatia S . Prostatic Artery Embolization in Refractory Hematuria of Prostatic Origin. Tech Vasc Interv Radiol. 2020; 23(3):100694. DOI: 10.1016/j.tvir.2020.100694. View

17.

Gilling P, Wilson L, King C, Westenberg A, Frampton C, Fraundorfer M . Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int. 2011; 109(3):408-11. DOI: 10.1111/j.1464-410X.2011.10359.x. View

18.

Lin Y, Wu X, Xu A, Ren R, Zhou X, Wen Y . Transurethral enucleation of the prostate versus transvesical open prostatectomy for large benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. World J Urol. 2015; 34(9):1207-19. DOI: 10.1007/s00345-015-1735-9. View

19.

Tsukamoto T, Masumori N, Rahman M, Crane M . Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally. Int J Urol. 2007; 14(4):321-4. DOI: 10.1111/j.1442-2042.2007.01596.x. View

20.

McVary K, Gange S, Gittelman M, Goldberg K, Patel K, Shore N . Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol. 2015; 195(5):1529-1538. DOI: 10.1016/j.juro.2015.10.181. View